A Phase 1 interventional study of Stryker1688 Fluorescence imaging system in Cholecystitis, sponsored by Stryker Endoscopy. Terminated at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-19.
Sponsored by Stryker Endoscopy (part of Stryker) · Phase 1, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Cholecystitis with a site in United States — 4 open to participants now, 4 under way, none of them phase 3. Cholecystitis · United States.
Among the 28 studies in Cholecystitis with a site in United States, this one is the 9th largest by enrollment of the 21 interventional ones that give a count, is one of 3 that started in 2021, is the only one in phase 1, and was the 23rd registered.
193 studies on the registry are indexed under Cholecystitis; 36 are open to participants now.
Browse Cholecystitis studies →4 of the 28 studies in Cholecystitis with a site in United States are open now. Recruiting first, the newest first:
Mayo Clinic · Sites in United States
Ages 18–95
Activ Surgical · Sites in United States
Ages 18+ · Healthy volunteers
Cision Vision, Inc. · Sites in United States
Ages 18–90
European Society for Trauma and Emergency Surgery · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 23 Cholecystitis studies recruiting now, 14 (61%) set no upper age limit and 7 (30%) stop at 75 or younger; 2 take children under 18; 5 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 50 is below the median of 82 across 129 interventional studies indexed under Cholecystitis.
Median enrollment 30 across the 21 interventional studies, 200 across the 7 observational. Of the 19 that completed or were terminated, 9 (47%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 28 have an industry lead sponsor. The 10 most frequent:
This study is registered under Stryker Endoscopy, one of the names counted as Stryker. Under that name alone:
Stryker Endoscopy is the lead sponsor of 4 studies on the registry; 3 are open to participants now.
Stryker has 2 studies filed under Cholecystitis — fewer than ten, so there is no comparison to draw.
2 of the studies in Cholecystitis with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07222527Mayo ClinicOne vs. Two Stents for Gallbladder Disease | 2027-05-27 |
| NCT07568080European Society for Trauma and Emergency SurgerySnapChole: An International, Time-Bound Prospective Platform Study of Management Strategies and Outcomes in Acute Calculous Cholecystitis | 2027-08-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 28 studies in Cholecystitis with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This is a prospective single arm, single center study estimating percentage of successful critical anatomy recognition in laparoscopic cholecystectomy surgeries using SPY fluorescence imaging and ICG, with each surgery also providing a white light 360 degree images.
The primary objective is to determine the percentage of successful critical anatomy recognition using intra-operative SPY fluorescence imaging and ICG: and to describe complications associated with intra-operative decision making in patients undergoing laparoscopic cholecystectomy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The purpose of this study is to use SPY fluorescence imaging systems and indocyanine green (ICG) as a tool to determine the percentage of successful critical anatomy recognition and to describe complications associated with intra-operative decision making in patients undergoing laparoscopic cholecystectomy.
Outcome 1
To determine the percentage of successful critical anatomy recognition using intra-operative SPY fluorescence imaging and ICG in subjects undergoing laparoscopic cholecystectomy
Time frame: Intra-op visit
Outcome 2
To estimate the number of times a surgeon altered the surgical plan due to information identified/revealed by SPY fluorescence imaging
Time frame: Intra-op visit
Outcome 3
To estimate the number of post-operative complications (related to gall bladder surgery
Time frame: Post op follow- up (7-14 days)
Plan to share: No
No publications or documents are linked to this record.
Ran from Jun 2021 to primary completion in Feb 2022, 7 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.